Cytokinetics (CYTK) Receivables - Other (2010 - 2019)
Cytokinetics (CYTK) posted quarterly Receivables - Other of $575000.0 for Q2 2019, down 94.46% year-over-year from $10.4 million in Q2 2018, and down 76.74% quarter-over-quarter from $2.5 million in Q1 2019.
Cytokinetics (CYTK) Receivables - Other (2010 - 2019) Analysis & Trends
Cytokinetics (CYTK) has reported Receivables - Other for 10 consecutive years, with $575000.0 the latest figure, recorded in Q2 2019.
- In Q2 2019, Receivables - Other fell 94.46% year-over-year to $575000.0; the TTM figure through Jun 2019 stood at $575000.0 (down 94.46% YoY), while the FY2018 annual figure was $4.6 million, down 53.09% from the prior year.
- Receivables - Other slipped to $575000.0 in Q2 2019 per CYTK's latest filing, from $2.5 million in the prior quarter.
- Across five years, Receivables - Other topped out at $67.0 million in Q3 2016 and bottomed at -$67.0 million in Q4 2016.
- Historically, Receivables - Other has averaged $315500.0 across 5 years, with a median of $742500.0 in 2017.
- On a YoY basis, Receivables - Other climbed as much as 142453.19% in 2016 and fell as far as 185944.44% in 2016.
- Cytokinetics' Receivables - Other stood at -$36000.0 in 2015, then sank by 185944.44% to -$67.0 million in 2016, then soared by 114.49% to $9.7 million in 2017, then tumbled by 53.09% to $4.6 million in 2018, then sank by 87.37% to $575000.0 in 2019.
- Business Quant data shows CYTK's Receivables - Other at $575000.0 in Q2 2019, $2.5 million in Q1 2019, and $4.6 million in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 575,000.00 |
| Jun 30, 2019 | 575,000.00 |
| Mar 31, 2019 | 2.47 Mn |
| Mar 31, 2019 | 2.47 Mn |
| Dec 31, 2018 | 4.55 Mn |
| Dec 31, 2018 | 4.55 Mn |
| Sep 30, 2018 | 5.88 Mn |
| Sep 30, 2018 | 5.88 Mn |
| Jun 30, 2018 | 10.38 Mn |
| Jun 30, 2018 | 10.38 Mn |
| Mar 31, 2018 | 16.20 Mn |
| Mar 31, 2018 | 16.20 Mn |
| Dec 31, 2017 | 9.71 Mn |
| Dec 31, 2017 | 9.71 Mn |
| Mar 31, 2017 | 910,000.00 |
| Mar 31, 2017 | 910,000.00 |
| Dec 31, 2016 | -66.98 Mn |
| Dec 31, 2016 | -66.98 Mn |
| Sep 30, 2016 | 67.00 Mn |
| Sep 30, 2016 | 67.00 Mn |